Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000363117

Medchemexpress LLC Indeglitazar | 835619-41-5 | 98.5% | 389.42 | 50 MG
SDP

Supplier:  Medchemexpress LLC HY1481750MG

Encompass_Preferred

Indeglitazar (PPM 204) is an orally available PPAR pan-agonist, effective for all three PPARα, PPARδ, and PPARγ. It is intended for research use only. In vivo studies have shown that treatment with Indeglitazar significantly lowers glucose, HbA1C, triglycerides, and total cholesterol.

  • Functions as an orally available pan-agonist for PPARα, PPARδ, and PPARγ
  • Exhibits an EC50 of 0.32 μM in preadipocyte differentiation assays
  • Significantly lowers glucose, HbA1C, triglycerides, and total cholesterol in animal models
  • Decreases insulin and free fatty acid levels in animal models of diabetes and insulin resistance

Catalog No. 50-003-63117


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.